ISPOR - SA36 Is Progression-Free Survival a Good Indicator of Overall Survival for Pazopanib in Patients With Synovial Sarcoma?

Full Text

SA36 Is Progression-Free Survival a Good Indicator of Overall Survival for Pazopanib in Patients With Synovial Sarcoma?

Abstract

Authors

J Han S Lee E Cho

Back to Volume 25, Supplemental Issue 12S

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now